Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo de Congresso
|
Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1Sara A. Hurvitz Fabrice Andre; Zefei Jiang; Zhimin Shao; Silvia P Neciosup; Max S Mano; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia M Dreosti; Jifeng Feng; Howard A Burris; Masakazu Toi; Marc E Buyse; David Cabaribere; Mary-Ann Lindsay; Tiffany Kunz; Shantha Rao; Lida B Pacaud; Tetiana Taran; Dennis Slamon; Annual CTRC-AACR San Antonio Breast Cancer Symposium (37. 2014 San Antonio, TX)Cancer Research Baltimore v. 75, abst. S6-01, May, 2015Baltimore 2015Acesso online. A biblioteca também possui exemplares impressos. |
|
2 |
Material Type: Artigo
|
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1) a phase 3, randomised, double-blind, multicentre trialSara A. Hurvitz Fabrice Andre; Zefei Jiang; Zhimin Shao; Max S Mano; Silvia P Neciosup; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia M Dreosti; Howard A Burris; Masakazu Toi; Marc E Buyse; David Cabaribere; Mary-Ann Lindsay; Shantha Rao; Lida Bubuteishvili Pacaud; Tetiana Taran; Dennis SlamonThe Lancet Oncology London v. 16, n. 7, p. 816-829, 2015London 2015Acesso online. A biblioteca também possui exemplares impressos. |